Zoetis Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Zoetis Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.47B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $9.26B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $8.54B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $8.08B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $7.78B | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $6.68B | Feb 14, 2023 |
| FY2019 | Dec 31, 2019 | $1.67B | Feb 13, 2020 |
| FY2019 | Sep 30, 2019 | $1.58B | Feb 13, 2020 |
| FY2019 | Jun 30, 2019 | $1.55B | Feb 13, 2020 |
| FY2019 | Mar 31, 2019 | $1.46B | Feb 13, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.46B | Feb 15, 2018 |
| FY2017 | Oct 1, 2017 | $1.35B | Feb 15, 2018 |
| FY2017 | Jul 2, 2017 | $1.27B | Feb 15, 2018 |
| FY2017 | Apr 2, 2017 | $1.23B | Feb 15, 2018 |
| FY2017 | Dec 31, 2016 | $1.28B | Feb 15, 2018 |
| FY2017 | Oct 2, 2016 | $1.24B | Feb 15, 2018 |
| FY2017 | Jul 3, 2016 | $1.21B | Feb 15, 2018 |
| FY2017 | Apr 3, 2016 | $1.16B | Feb 15, 2018 |
| FY2016 | Dec 31, 2015 | $1.27B | Feb 16, 2017 |
| FY2016 | Sep 27, 2015 | $1.21B | Feb 16, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.67B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $2.49B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $2.34B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $2.11B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $2.04B | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $1.64B | Feb 14, 2023 |
| FY2019 | Dec 31, 2019 | $384.00M | Feb 13, 2020 |
| FY2019 | Sep 30, 2019 | $433.00M | Feb 13, 2020 |
| FY2019 | Jun 30, 2019 | $371.00M | Feb 13, 2020 |
| FY2019 | Mar 31, 2019 | $312.00M | Feb 13, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.38B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $2.32B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $2.15B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $2.01B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $2.00B | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $1.73B | Feb 14, 2023 |
| FY2021 | Dec 31, 2019 | $1.64B | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $1.48B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $1.33B | Feb 13, 2020 |
| FY2018 | Dec 31, 2016 | $1.36B | Feb 14, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.90B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $2.95B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $2.35B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $1.91B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $2.21B | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $2.13B | Feb 14, 2023 |
| FY2021 | Dec 31, 2019 | $1.80B | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $1.79B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $1.35B | Feb 13, 2020 |
| FY2018 | Dec 31, 2016 | $713.00M | Feb 14, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $621.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $655.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $732.00M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $586.00M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $477.00M | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $453.00M | Feb 14, 2023 |
| FY2021 | Dec 31, 2019 | $460.00M | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $338.00M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $224.00M | Feb 13, 2020 |
| FY2018 | Dec 31, 2016 | $216.00M | Feb 14, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.47B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $14.24B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $14.29B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $14.93B | Feb 13, 2024 |
| FY2022 | Dec 31, 2021 | $13.90B | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $13.61B | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $11.55B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $10.78B | Feb 13, 2020 |
| FY2018 | Dec 31, 2017 | $8.59B | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $7.65B | Feb 15, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.14B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $9.47B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $9.30B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $10.52B | Feb 13, 2024 |
| FY2022 | Dec 31, 2021 | $9.36B | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $9.84B | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $8.84B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $8.59B | Feb 13, 2020 |
| FY2018 | Dec 31, 2017 | $6.80B | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $6.15B | Feb 15, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.33B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $4.77B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $5.00B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $4.41B | Feb 13, 2024 |
| FY2022 | Dec 31, 2021 | $4.54B | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $3.77B | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $2.71B | Feb 16, 2021 |
| FY2018 | Dec 31, 2018 | $2.19B | Feb 14, 2019 |
| FY2018 | Dec 31, 2017 | $1.77B | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $1.49B | Feb 15, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.77B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $2.72B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $2.76B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $2.75B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $2.68B | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $2.69B | Feb 14, 2023 |
| FY2021 | Dec 31, 2019 | $2.59B | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $2.52B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $1.51B | Feb 13, 2020 |
| FY2018 | Dec 31, 2016 | $1.48B | Feb 14, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.74B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $11.97B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $10.30B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $8.67B | Feb 13, 2024 |
| FY2022 | Dec 31, 2021 | $7.19B | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $5.66B | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $4.43B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $3.27B | Feb 13, 2020 |
| FY2018 | Dec 31, 2017 | $2.11B | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $1.48B | Feb 15, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.56B | Feb 15, 2018 |
| FY2017 | Dec 31, 2016 | $727.00M | Feb 15, 2018 |
| FY2017 | Dec 31, 2015 | $1.15B | Feb 15, 2018 |
| FY2017 | Dec 31, 2014 | $882.00M | Feb 15, 2018 |
| FY2016 | Dec 31, 2013 | $610.00M | Feb 16, 2017 |
| FY2015 | Dec 31, 2012 | $317.00M | Feb 24, 2016 |
| FY2013 | Dec 31, 2011 | $79.00M | Mar 26, 2014 |
| FY2013 | Dec 31, 2010 | $63.00M | Mar 26, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 5 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | 4 | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | 3 | Feb 14, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 13, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 5 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | 4 | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | 3 | Feb 14, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 13, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 424.93M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 448.47M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | 458.37M | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | 463.81M | Feb 13, 2024 |
| FY2022 | Dec 31, 2021 | 472.57M | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | 475.32M | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | 475.53M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | 479.56M | Feb 13, 2020 |
| FY2018 | Dec 31, 2017 | 486.13M | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | 492.86M | Feb 15, 2018 |